An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing market exists on messaging services, where groups with numerous of members share comparison photos, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Experts Voice Worries
However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.
Several experts stated the popularity for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Reaction and Content Elimination
According to the social media company, the platform has removed violative content and banned related keywords and search suggestions. The organization stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Trading Activities
Investigations also found groups with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with photos of slimming results, glowing reviews and step-by-step guides for preparing or injecting at residence.
After moments of entering one community, a seller posted contact information, where most transactions take place. The seller provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, health issues or past usage.
Product Information and Pricing
Inside these communities, posts show dark colored packages with Royal Mail labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When questioned how much time a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for the messaging service said it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering materials they cannot confirm. Although the research behind retatrutide is valid, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her team has already seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly serious medical dangers”.
